wy 48252 has been researched along with Innate Inflammatory Response in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Musser, JH | 1 |
| Bender, RH; Carlson, RP; Chang, J; Hand, JM; Kreft, AF; Kubrak, DM; Musser, JH | 1 |
| Borgeat, P; Chang, J; Hand, JM; Marshall, LA; Musser, JH; Schleimer, RP | 1 |
1 review(s) available for wy 48252 and Innate Inflammatory Response
| Article | Year |
|---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
2 other study(ies) available for wy 48252 and Innate Inflammatory Response
| Article | Year |
|---|---|
N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
Topics: Acetophenones; Animals; Bronchi; Chemical Phenomena; Chemistry; Constriction, Pathologic; Cyclooxygenase Inhibitors; Cysteine; Edema; Guinea Pigs; Hydroxyquinolines; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Molecular Structure; Muscle Contraction; Naphthalenes; SRS-A; Structure-Activity Relationship; Sulfonamides; Tetrazoles; Trachea | 1989 |
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]membrane sulfonamide), an orally active leukotriene antagonist: effects on arachidonic acid metabolism in various inflammatory cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cattle; Eicosanoic Acids; Female; Histamine Release; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyquinolines; Inflammation; Lung; Macrophages; Mice; Rats; Rats, Inbred Strains; SRS-A | 1988 |